Common Stock, Shares, Outstanding of Raphael Pharmaceutical Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Raphael Pharmaceutical Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Raphael Pharmaceutical Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 19,626,418, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Raphael Pharmaceutical Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 19,626,418 +925,000 +4.9% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 19,626,418 +925,000 +4.9% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 19,626,418 +965,000 +5.2% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 18,701,418 +198,500 +1.1% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 18,701,418 +599,000 +3.3% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 18,701,418 +2,333,250 +14% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 18,661,418 +2,658,628 +17% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 18,502,918 +2,878,878 +18% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 18,102,418 +2,618,378 +17% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 16,368,168 +2,142,628 +15% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 16,002,790 +2,712,250 +20% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 15,624,040 +2,653,500 +20% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 15,484,040 +3,341,250 +28% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,225,540 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 13,290,540 +13,290,440 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 12,970,540 +3,511,287 +37% 31 Dec 2021 10-K/A 25 May 2023 2022 FY
Q3 2021 12,142,790 30 Sep 2021 10-Q 16 Nov 2021 2021 Q3
Q1 2021 100* 14 May 2021 10-Q 15 May 2024 2024 Q1
Q4 2020 9,459,253 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.